The creation of the nuclease-dead Cas protein (dCas9) offers a new platform for a plethora of new discoveries. Diverse dCas9 tools have been developed for transcription regulation, epigenetic engineering, base editing, genome imaging, genetic screens, and chromatin immunoprecipitation. Here, we show that dCas9 and single-guide RNA preassembled to form ribonucleoprotein dCas9–sgRNA (referred to as dRNP) is capable of specifically and reversibly blocking the activity of DNA cleavage by restriction enzymes (REs). We show that the inhibition of RE activities occurs when the recognition or the cleavage site of the DNA is overlapped by the sgRNA or the protospacer adjacent motif sequence. Furthermore, we show that multiple dRNPs can be used simultaneously to inhibit more than one RE sites. As such, we exploited this novel finding as a method to demonstrate that inserts can be ligated into vectors, and vice versa, whereby selective RE sites are temporarily sheltered to allow the desired cloning.
Get full access to this article
View all access options for this article.
References
1.
AbudayyehOO, GootenbergJS, EssletzbichlerP, et al.RNA targeting with CRISPR-Cas13. Nature, 2017; 550:280–284. DOI: 10.1038/nature24049.
2.
CongL, RanFA, CoxD, et al.Multiplex genome engineering using CRISPR/Cas systems. Science, 2013; 339:819–823. DOI: 10.1126/science.1231143.
3.
HsuPD, ScottDA, WeinsteinJA, et al.DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol, 2013; 31:827–832. DOI: 10.1038/nbt.2647.
4.
JinekM, ChylinskiK, FonfaraI, et al.A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science, 2012; 337:816–821. DOI: 10.1126/science.1225829.
5.
RanFA, HsuPD, WrightJ, et al.Genome engineering using the CRISPR-Cas9 system. Nat Protoc, 2013; 8:2281–2308. DOI: 10.1038/nprot.2013.143.
6.
ZetscheB, GootenbergJS, AbudayyehOO, et al.Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell, 2015; 163:759–771. DOI: 10.1016/j.cell.2015.09.038.
7.
JinekM, EastA, ChengA, et al.RNA-programmed genome editing in human cells. Elife, 2013; 2:e00471. DOI: 10.7554/eLife.00471.
8.
MaliP, YangL, EsveltKM, et al.RNA-guided human genome engineering via Cas9. Science, 2013; 339:823–826. DOI: 10.1126/science.1232033.
9.
QiLS, LarsonMH, GilbertLA, et al.Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell, 2013; 152:1173–1183. DOI: 10.1016/j.cell.2013.02.022.
10.
FarzadfardF, PerliSD, LuTK. Tunable and multifunctional eukaryotic transcription factors based on CRISPR/Cas. ACS Synth Biol, 2013; 2:604–613. DOI: 10.1021/sb400081r.
11.
AouidaM, EidA, AliZ, et al.Efficient fdCas9 synthetic endonuclease with improved specificity for precise genome engineering. PLoS One, 2015; 10:e0133373. DOI: 10.1371/journal.pone.0133373.
12.
FujitaT, FujiiH. Efficient isolation of specific genomic regions and identification of associated proteins by engineered DNA-binding molecule-mediated chromatin immunoprecipitation (enChIP) using CRISPR. Biochem Biophys Res Commun, 2013; 439:132–136. DOI: 10.1016/j.bbrc.2013.08.013.
13.
GilbertLA, HorlbeckMA, AdamsonB, et al.Genome-scale CRISPR-mediated control of gene repression and activation. Cell, 2014; 159:647–661. DOI: 10.1016/j.cell.2014.09.029.
14.
GuilingerJP, ThompsonDB, LiuDR. Fusion of catalytically inactive Cas9 to FokI nuclease improves the specificity of genome modification. Nat Biotechnol, 2014; 32:577–582. DOI: 10.1038/nbt.2909.
15.
HiltonIB, D'IppolitoAM, VockleyCM, et al.Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers. Nat Biotechnol, 2015; 33:510–517. DOI: 10.1038/nbt.3199.
16.
KimYB, KomorAC, LevyJM, et al.Increasing the genome-targeting scope and precision of base editing with engineered Cas9-cytidine deaminase fusions. Nat Biotechnol, 2017; 35:371–376. DOI: 10.1038/nbt.3803.
17.
KomorAC, KimYB, PackerMS, et al.Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature, 2016; 533:420–424. DOI: 10.1038/nature17946.
18.
KonermannS, BrighamMD, TrevinoAE, et al.Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature, 2015; 517:583–588. DOI: 10.1038/nature14136.
19.
QinP, ParlakM, KuscuC, et al.Live cell imaging of low- and non-repetitive chromosome loci using CRISPR-Cas9. Nat Commun, 2017; 8:14725. DOI: 10.1038/ncomms14725.
20.
TsaiSQ, WyvekensN, KhayterC, et al.Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing. Nat Biotechnol, 2014; 32:569–576. DOI: 10.1038/nbt.2908.
21.
FujitaT, YunoM, FujiiH. Efficient sequence-specific isolation of DNA fragments and chromatin by in vitro enChIP technology using recombinant CRISPR ribonucleoproteins. Genes Cells, 2016; 21:370–377. DOI: 10.1111/gtc.12341.
22.
GilbertLA, LarsonMH, MorsutL, et al.CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell, 2013; 154:442–451. DOI: 10.1016/j.cell.2013.06.044.
23.
PiatekA, AliZ, BaazimH, et al.RNA-guided transcriptional regulation in planta via synthetic dCas9-based transcription factors. Plant Biotechnol J, 2015; 13:578–589. DOI: 10.1111/pbi.12284.
GaudelliNM, KomorAC, ReesHA, et al.Programmable base editing of A*T to G*C in genomic DNA without DNA cleavage. Nature, 2017; 551:464–471. DOI: 10.1038/nature24644.
26.
AntonT, BultmannS, LeonhardtH, et al.Visualization of specific DNA sequences in living mouse embryonic stem cells with a programmable fluorescent CRISPR/Cas system. Nucleus, 2014; 5:163–172. DOI: 10.4161/nucl.28488.
27.
ChenB, GilbertLA, CiminiBA, et al.Dynamic imaging of genomic loci in living human cells by an optimized CRISPR/Cas system. Cell, 2013; 155:1479–1491. DOI: 10.1016/j.cell.2013.12.001.
28.
FujitaT, FujiiH. Identification of proteins associated with an IFNgamma-responsive promoter by a retroviral expression system for enChIP using CRISPR. PLoS One, 2014; 9:e103084. DOI: 10.1371/journal.pone.0103084.
29.
FujitaT, YunoM, OkuzakiD, et al.Identification of non-coding RNAs associated with telomeres using a combination of enChIP and RNA sequencing. PLoS One, 2015; 10:e0123387. DOI: 10.1371/journal.pone.0123387.
30.
FujitaT, YunoM, SuzukiY, et al.Identification of physical interactions between genomic regions by enChIP-Seq. Genes Cells, 2017; 22:506–520. DOI: 10.1111/gtc.12492.
31.
ZhangY, HuJF, WangH, et al.CRISPR Cas9-guided chromatin immunoprecipitation identifies miR483 as an epigenetic modulator of IGF2 imprinting in tumors. Oncotarget, 2017; 8:34177–34190. DOI: 10.18632/oncotarget.10918.
32.
XuX, QiLS. A CRISPR-dCas toolbox for genetic engineering and synthetic biology. J Mol Biol, 2019; 431:34–47. DOI: 10.1016/j.jmb.2018.06.037.
33.
ChoSW, KimS, KimY, et al.Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases. Genome Res, 2014; 24:132–141. DOI: 10.1101/gr.162339.113.
34.
CradickTJ, FineEJ, AnticoCJ, et al.CRISPR/Cas9 systems targeting beta-globin and CCR5 genes have substantial off-target activity. Nucleic Acids Res, 2013; 41:9584–9592. DOI: 10.1093/nar/gkt714.
35.
FuY, SanderJD, ReyonD, et al.Improving CRISPR-Cas nuclease specificity using truncated guide RNAs. Nat Biotechnol, 2014; 32:279–284. DOI: 10.1038/nbt.2808.
36.
KuscuC, ArslanS, SinghR, et al.Genome-wide analysis reveals characteristics of off-target sites bound by the Cas9 endonuclease. Nat Biotechnol, 2014; 32:677–683. DOI: 10.1038/nbt.2916.
37.
LinY, CradickTJ, BrownMT, et al.CRISPR/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequences. Nucleic Acids Res, 2014; 42:7473–7485. DOI: 10.1093/nar/gku402.
38.
ChengAW, WangH, YangH, et al.Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system. Cell Res, 2013; 23:1163–1171. DOI: 10.1038/cr.2013.122.
39.
FerreiraR, SkrekasC, NielsenJ, et al.Multiplexed CRISPR/Cas9 genome editing and gene regulation using Csy4 in Saccharomyces cerevisiae. ACS Synth Biol, 2018; 7:10–15. DOI: 10.1021/acssynbio.7b00259.
40.
KurataM, WolfNK, LahrWS, et al.Highly multiplexed genome engineering using CRISPR/Cas9 gRNA arrays. PLoS One, 2018; 13:e0198714. DOI: 10.1371/journal.pone.0198714.
41.
McCartyNS, GrahamAE, StudenaL, et al.Multiplexed CRISPR technologies for gene editing and transcriptional regulation. Nat Commun, 2020; 11:1281. DOI: 10.1038/s41467-020-15053-x.
42.
XieK, MinkenbergB, YangY. Boosting CRISPR/Cas9 multiplex editing capability with the endogenous tRNA-processing system. Proc Natl Acad Sci U S A, 2015; 112:3570–3575. DOI: 10.1073/pnas.1420294112.
43.
FujitaT, FujiiH. Purification of specific DNA species using the CRISPR system. Biol Methods Protoc, 2019; 4:bpz008. DOI: 10.1093/biomethods/bpz008.
44.
UygunZO, YeniayL, Gi RgiNSF. CRISPR-dCas9 powered impedimetric biosensor for label-free detection of circulating tumor DNAs. Anal Chim Acta, 2020; 1121:35–41. DOI: 10.1016/j.aca.2020.04.009.
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
